Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
Hsing-Chen Tsai(National Yang Ming Chiao Tung University), Cynthia A. Zahnow(Johns Hopkins University), Il Minn(Southwestern Medical Center), Lonny Yarmus(Johns Hopkins University), William Matsui(The University of Texas at Austin), James Shin(Johns Hopkins University), Feyruz V. Rassool(University of Maryland, Baltimore), Yoon-Young Jang(Johns Hopkins University), Vered Stearns(Johns Hopkins University), Stephen B. Baylin(Johns Hopkins University), Jean‐Pierre J. Issa(Coriell Institute For Medical Research), Kirsten Harbom(Johns Hopkins Hospital), Emmanouil P. Pappou(Memorial Sloan Kettering Cancer Center), Yi Cai(Johns Hopkins University), David Feller‐Kopman(Dartmouth–Hitchcock Medical Center), Nita Ahuja(Johns Hopkins University), James Harris(Monash Health), Huili Li(Johns Hopkins University), Yi‐Chun Lin(Ministry of Health and Welfare), Carine Robert(University of Maryland, Baltimore), Malcolm V. Brock(Johns Hopkins University), Ray-Whay Chiu Yen(Johns Hopkins University), Robert M. Beaty(Sidney Kimmel Comprehensive Cancer Center), Alana L. Welm(Huntsman Cancer Institute), Saul J. Sharkis(Johns Hopkins University), Leander Van Neste(Maastricht University)
Cited by 652
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Epigenetic Determinants of Cancer
|Cold Spring Harbor Perspectives in Biology|2016|1.3k